CGGRGD TFA (1260223-44-6 free base) TP1668
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT)[1].
CAS nr:
TP1668
Purity:
98%
Molecular Weight:
677,61
SMILES:
Formula:
C21H34F3N9O11S
Pathway:
Target:
